Published in Cancer on August 01, 1975
Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy. Ann Surg (1984) 1.23
Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome. Br J Cancer (1982) 1.07
Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug. Br J Cancer (1986) 0.98
The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer. Br J Cancer (1994) 0.90
Recent advances in cytotoxic therapy for gastrointestinal carcinoma: a review. J R Soc Med (1978) 0.87
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study. Br J Cancer (2003) 0.84
Surgical excision alone is adequate treatment for primary colorectal cancer. Ann R Coll Surg Engl (1992) 0.82
Chemotherapy in advanced gastric cancer: a controlled, prospective, randomised multi-centre study. Gut (1979) 0.81
Cancer chemotherapy: past, present, and future--Part I. J Natl Med Assoc (1984) 0.81
Cytological screening for cancer of the stomach. Proc R Soc Med (1976) 0.81
A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer. Br J Cancer (1999) 0.79
Progress report. Cytotoxic therapy for gastrointestinal carcinoma. Gut (1976) 0.79
Pyrimidine nucleoside phosphorylase activity in tumour and matched normal gastrointestinal mucosa. Gut (1982) 0.79
Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET). PLoS One (2016) 0.79
Editorial: Adjuvant chemotherapy in colorectal cancer. Br Med J (1976) 0.75
Update in cancer chemotherapy: gastrointestinal cancer, cancer of the small intestines, gallbladder, liver, and esophagus. J Natl Med Assoc (1986) 0.75
Update in cancer chemotherapy: gastrointestinal cancer--colorectal cancer, Part 1. J Natl Med Assoc (1986) 0.75
Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med (1991) 7.21
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
The physician's responsibility toward hopelessly ill patients. A second look. N Engl J Med (1989) 4.20
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol (1989) 4.03
Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA (1993) 3.91
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol (1989) 3.44
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med (1985) 3.36
Carcinoid tumors of the vermiform appendix. Cancer (1968) 3.07
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med (1998) 2.95
Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet (1969) 2.94
Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med (1980) 2.72
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med (1986) 2.70
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med (1979) 2.63
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol (1998) 2.51
The physician's responsibility toward hopelessly ill patients. N Engl J Med (1984) 2.46
Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol (1983) 2.41
Surgical management of multiple polyposis. The problem of cancer in the retained bowel segment. Arch Surg (1970) 2.31
Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. J Clin Oncol (1985) 2.26
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med (1997) 2.25
Survival after postoperative combination treatment of rectal cancer. N Engl J Med (1986) 2.24
Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet (1992) 2.15
Multiple primary malignant neoplasms: historical perspectives. Cancer (1977) 2.11
Controlled clinical studies of orally administered antiemetic drugs. Gastroenterology (1969) 1.92
Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med (1977) 1.84
The effect of measuring error on the results of therapeutic trials in advanced cancer. Cancer (1976) 1.81
Mesenteric lipodystrophy. Ann Intern Med (1974) 1.80
Treatment of the patient with adenocarcinoma of unknown origin. Cancer (1972) 1.79
Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res (1975) 1.75
Rectal cancer following colectomy for polyposis. Arch Surg (1980) 1.63
Chemotherapy of gastrointestinal cancer. N Engl J Med (1978) 1.56
Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer (1984) 1.52
The routine proctoscopic examination: a second look. Mayo Clin Proc (1966) 1.51
The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer (1986) 1.50
A comparative evaluation of marketed analgesic drugs. N Engl J Med (1972) 1.50
Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial. Int J Radiat Oncol Biol Phys (1996) 1.50
Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery (1990) 1.47
A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. N Engl J Med (1982) 1.47
Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol (1984) 1.46
Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol (1984) 1.44
Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer Clin Trials (1979) 1.41
Usefulness of serial serum carcinoembryonic antigen (CEA) determinations during anticancer therapy or long-term follow-up of gastrointestinal carcinoma. Cancer (1974) 1.40
Off-label drug use for cancer therapy and national health care priorities. JAMA (1991) 1.40
Vaccine adjuvant therapy for colorectal cancer: "very dramatic" or ho-hum? J Clin Oncol (1993) 1.39
Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer (1974) 1.37
Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detection. JAMA (1978) 1.35
Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine. J Natl Cancer Inst (1975) 1.32
A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma. J Clin Oncol (1985) 1.29
Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer (1984) 1.28
Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. Cancer Chemother Rep (1974) 1.24
Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group. Arch Surg (1990) 1.21
The malignant carcinoid syndrome. Surg Gynecol Obstet (1973) 1.15
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. Ann Intern Med (1979) 1.14
Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer. Cancer Chemother Rep (1972) 1.13
Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial. Cancer (1978) 1.13
Carcinoids: the association of histologic growth pattern and survival. Cancer (1983) 1.13
Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer (1989) 1.12
Relief of pain by oral medications. A controlled evaluation of analgesic combinations. JAMA (1974) 1.12
A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin. Cancer (1990) 1.12
Management of nausea and vomiting in the cancer patient. JAMA (1981) 1.11
The natural history of advanced gastric cancer. Surg Gynecol Obstet (1968) 1.11
Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc (1985) 1.10
Primary liver cancer. An Eastern Cooperative Oncology Group Trial. Cancer (1984) 1.10
Chemotherapy of gastrointestinal cancer. Clin Gastroenterol (1976) 1.10
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group. J Clin Oncol (1994) 1.09
Combination chemotherapy in gastrointestinal cancer. Cancer Res (1970) 1.08
Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg (1987) 1.08
Proceedings: A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer. Cancer (1974) 1.08
Peritoneal mesothelioma. Gastroenterology (1972) 1.08
A pharmacologic and toxicological study of amygdalin. JAMA (1981) 1.06
DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer (1991) 1.05
Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med (1987) 1.05
Sequential and combination chemotherapy of advanced gastric cancer. Cancer (1976) 1.04
A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas. J Clin Oncol (1986) 1.03
Who responds to sugar pills? Mayo Clin Proc (1976) 1.03
Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol (1992) 1.02
A phase I clinical trial of recombinant human tumor necrosis factor. Cancer (1988) 1.02
Improving accrual into cancer clinical trials. J Cancer Educ (1991) 1.01
Rapid reversal of carcinoid crisis with a somatostatin analogue. N Engl J Med (1985) 0.99
A comparison of 5-fluorouracil administered by slow infusion and rapid injection. Cancer Res (1972) 0.99
Colonic motility in ulcerative colitis after opiate administration. Gastroenterology (1967) 0.98
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group Report. Cancer (1978) 0.96
On lymphokines, cytokines, and breakthroughs. JAMA (1986) 0.95
Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer. Cancer Res (1975) 0.95
Mitomycin C therapy in advanced gastrointestinal cancer. JAMA (1968) 0.94
The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide. Yale J Biol Med (1993) 0.94
Correlation of histopathologic characteristics of primary tumor and uninvolved regional lymph nodes in Dukes' class C colonic carcinoma with prognosis. Mayo Clin Proc (1980) 0.94
Phase II trial of doxorubicin therapy for advanced islet cell carcinoma. Cancer Treat Rep (1982) 0.94
The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer. Cancer (1975) 0.94
Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer. Cancer (1983) 0.93
Hepatoma in the noncirrhotic liver. Cancer (1988) 0.92
Incidence and significance of multiple primary malignant neoplasms. Ann N Y Acad Sci (1964) 0.91
Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5-fluorouracil and streptozotocin plus cyclophosphamide. Cancer (1977) 0.91
Care of the patient with advanced cancer. JAMA (1980) 0.91
A prospective controlled evaluation of combined pelvic radiotherapy and methanol extraction residue of BCG (MER) for locally unresectable or recurrent rectal carcinoma. Int J Radiat Oncol Biol Phys (1982) 0.91
Gallbladder adenocarcinoma: prognostic significance of tumor acid mucopolysaccharide content. J Surg Oncol (1986) 0.90
Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study. J Clin Oncol (1995) 0.90